BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fenofibrate
,
rs3825942
,
MYC
,
Angiogenesis
,
Pseudomonas infection
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ERBB2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Conjunctiva
Breast tissue
Kidney
Kidney cortex
Placenta
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hepatocellular dysplasia
Irritable bowel syndrome
11p partial monosomy syndrome
Edema
Bacteremia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
tolfenamic acid
trastuzumab
picrotoxinin
Xamoterol
phensuximide
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
DST
SCML2
TPI1
SFRP1
LGALS4
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Biased activation of the receptor tyrosine kinase HER2.
Inhibition of mutationally activated HER2.
Zanidatamab Is Safe and Efficacious in HER2-Expressing/Amplified Cancers.
Therapeutic Strategies Targeting HER2 for Gastric Cancer].
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Breast Cancer With Over-expression of erbB2-BRAINSTORM
ErbB2 Positive Metastatic Breast Cancer
Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive M…
Brain Metastases In ErbB2-Positive Breast Cancer
Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Po…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ